513 related articles for article (PubMed ID: 27115515)
1. A Selective Transforming Growth Factor-β Ligand Trap Attenuates Pulmonary Hypertension.
Yung LM; Nikolic I; Paskin-Flerlage SD; Pearsall RS; Kumar R; Yu PB
Am J Respir Crit Care Med; 2016 Nov; 194(9):1140-1151. PubMed ID: 27115515
[TBL] [Abstract][Full Text] [Related]
2. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.
Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW
Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267
[TBL] [Abstract][Full Text] [Related]
3. Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension.
Zaiman AL; Podowski M; Medicherla S; Gordy K; Xu F; Zhen L; Shimoda LA; Neptune E; Higgins L; Murphy A; Chakravarty S; Protter A; Sehgal PB; Champion HC; Tuder RM
Am J Respir Crit Care Med; 2008 Apr; 177(8):896-905. PubMed ID: 18202349
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia induces downregulation of PPAR-γ in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-β signaling.
Gong K; Xing D; Li P; Aksut B; Ambalavanan N; Yang Q; Nozell SE; Oparil S; Chen YF
Am J Physiol Lung Cell Mol Physiol; 2011 Dec; 301(6):L899-907. PubMed ID: 21926264
[TBL] [Abstract][Full Text] [Related]
5. Platelet-Derived TGF (Transforming Growth Factor)-β1 Enhances the Aerobic Glycolysis of Pulmonary Arterial Smooth Muscle Cells by PKM2 (Pyruvate Kinase Muscle Isoform 2) Upregulation.
Zhu Y; Shu D; Gong X; Lu M; Feng Q; Zeng XB; Zhang H; Gao J; Guo YW; Liu L; Ma R; Zhu L; Hu Q; Ming ZY
Hypertension; 2022 May; 79(5):932-945. PubMed ID: 35232222
[TBL] [Abstract][Full Text] [Related]
6. Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling.
Chen YF; Feng JA; Li P; Xing D; Zhang Y; Serra R; Ambalavanan N; Majid-Hassan E; Oparil S
J Appl Physiol (1985); 2006 Feb; 100(2):564-71. PubMed ID: 16223981
[TBL] [Abstract][Full Text] [Related]
7. Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotaline.
Thomas M; Docx C; Holmes AM; Beach S; Duggan N; England K; Leblanc C; Lebret C; Schindler F; Raza F; Walker C; Crosby A; Davies RJ; Morrell NW; Budd DC
Am J Pathol; 2009 Feb; 174(2):380-9. PubMed ID: 19116361
[TBL] [Abstract][Full Text] [Related]
8. TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms.
Angelov SN; Hu JH; Wei H; Airhart N; Shi M; Dichek DA
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2102-2113. PubMed ID: 28729364
[TBL] [Abstract][Full Text] [Related]
9. The potential of asiaticoside for TGF-β1/Smad signaling inhibition in prevention and progression of hypoxia-induced pulmonary hypertension.
Wang XB; Wang W; Zhu XC; Ye WJ; Cai H; Wu PL; Huang XY; Wang LX
Life Sci; 2015 Sep; 137():56-64. PubMed ID: 26209140
[TBL] [Abstract][Full Text] [Related]
10. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth.
Smith JD; Bryant SR; Couper LL; Vary CP; Gotwals PJ; Koteliansky VE; Lindner V
Circ Res; 1999 May; 84(10):1212-22. PubMed ID: 10347096
[TBL] [Abstract][Full Text] [Related]
11. Endothelial injury in a transforming growth factor β-dependent mouse model of scleroderma induces pulmonary arterial hypertension.
Derrett-Smith EC; Dooley A; Gilbane AJ; Trinder SL; Khan K; Baliga R; Holmes AM; Hobbs AJ; Abraham D; Denton CP
Arthritis Rheum; 2013 Nov; 65(11):2928-39. PubMed ID: 23839959
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of overactive transforming growth factor-β signaling by prostacyclin analogs in pulmonary arterial hypertension.
Ogo T; Chowdhury HM; Yang J; Long L; Li X; Torres Cleuren YN; Morrell NW; Schermuly RT; Trembath RC; Nasim MT
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):733-41. PubMed ID: 23418342
[TBL] [Abstract][Full Text] [Related]
13. Key role of the endothelial TGF-β/ALK1/endoglin signaling pathway in humans and rodents pulmonary hypertension.
Gore B; Izikki M; Mercier O; Dewachter L; Fadel E; Humbert M; Dartevelle P; Simonneau G; Naeije R; Lebrin F; Eddahibi S
PLoS One; 2014; 9(6):e100310. PubMed ID: 24956016
[TBL] [Abstract][Full Text] [Related]
14. Injury-Induced Shedding of Extracellular Vesicles Depletes Endothelial Cells of Cav-1 (Caveolin-1) and Enables TGF-β (Transforming Growth Factor-β)-Dependent Pulmonary Arterial Hypertension.
Oliveira SDS; Chen J; Castellon M; Mao M; Raj JU; Comhair S; Erzurum S; Silva CLM; Machado RF; Bonini MG; Minshall RD
Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1191-1202. PubMed ID: 30943774
[TBL] [Abstract][Full Text] [Related]
15. Berberine attenuates hypoxia-induced pulmonary arterial hypertension via bone morphogenetic protein and transforming growth factor-β signaling.
Chen M; Shen H; Zhu L; Yang H; Ye P; Liu P; Gu Y; Chen S
J Cell Physiol; 2019 Aug; 234(10):17482-17493. PubMed ID: 30786011
[TBL] [Abstract][Full Text] [Related]
16. A transforming growth factor-beta antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury.
Ruocco A; Nicole O; Docagne F; Ali C; Chazalviel L; Komesli S; Yablonsky F; Roussel S; MacKenzie ET; Vivien D; Buisson A
J Cereb Blood Flow Metab; 1999 Dec; 19(12):1345-53. PubMed ID: 10598939
[TBL] [Abstract][Full Text] [Related]
17. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins.
Morrell NW; Yang X; Upton PD; Jourdan KB; Morgan N; Sheares KK; Trembath RC
Circulation; 2001 Aug; 104(7):790-5. PubMed ID: 11502704
[TBL] [Abstract][Full Text] [Related]
18. Sulfur Dioxide Protects Against Collagen Accumulation in Pulmonary Artery in Association With Downregulation of the Transforming Growth Factor β1/Smad Pathway in Pulmonary Hypertensive Rats.
Yu W; Liu D; Liang C; Ochs T; Chen S; Chen S; Du S; Tang C; Huang Y; Du J; Jin H
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792648
[TBL] [Abstract][Full Text] [Related]
19. Danshensu prevents hypoxic pulmonary hypertension in rats by inhibiting the proliferation of pulmonary artery smooth muscle cells via TGF-β-smad3-associated pathway.
Zhang N; Dong M; Luo Y; Zhao F; Li Y
Eur J Pharmacol; 2018 Feb; 820():1-7. PubMed ID: 29221952
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury.
Ward MR; Agrotis A; Kanellakis P; Dilley R; Jennings G; Bobik A
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2461-70. PubMed ID: 9409216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
